# Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years

> **NCT04821310** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 43 (actual)

## Conditions studied

- Esophagitis

## Interventions

- **DRUG:** Full dose Pantoprazole plus matching placebo
- **DRUG:** Half Dose Pantoprazole plus matching placebo

## Key facts

- **NCT ID:** NCT04821310
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-13
- **Primary completion:** 2025-12-16
- **Final completion:** 2025-12-16
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** Pfizer has made an internal business decision to terminate the B1791094 study. This decision was not due to safety concerns or requests from any regulatory authorities.
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821310, "Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04821310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*